22060
The selective once - daily prandial glucagon - like peptide - 1 ( GLP - 1 ) receptor agonist lixisenatide ( Lyxumia ( (R) ) ) is under development with Sanofi for the treatment of type 2 diabetes mellitus .
 None
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 None